Compare BNTX & CTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BNTX | CTRA |
|---|---|---|
| Founded | 2008 | 1989 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.8B | 20.1B |
| IPO Year | 2019 | 1990 |
| Metric | BNTX | CTRA |
|---|---|---|
| Price | $96.21 | $26.51 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 16 |
| Target Price | ★ $137.40 | $32.75 |
| AVG Volume (30 Days) | 1.1M | ★ 8.3M |
| Earning Date | 11-03-2025 | 11-03-2025 |
| Dividend Yield | N/A | ★ 3.33% |
| EPS Growth | N/A | ★ 31.20 |
| EPS | N/A | ★ 2.17 |
| Revenue | $3,698,814,972.00 | ★ $6,666,000,000.00 |
| Revenue This Year | N/A | $47.08 |
| Revenue Next Year | $9.49 | $7.39 |
| P/E Ratio | ★ N/A | $12.18 |
| Revenue Growth | 3.70 | ★ 25.92 |
| 52 Week Low | $81.20 | $22.33 |
| 52 Week High | $129.27 | $29.95 |
| Indicator | BNTX | CTRA |
|---|---|---|
| Relative Strength Index (RSI) | 38.91 | 59.01 |
| Support Level | $94.00 | $25.20 |
| Resistance Level | $104.05 | $27.24 |
| Average True Range (ATR) | 3.41 | 0.64 |
| MACD | -0.46 | -0.00 |
| Stochastic Oscillator | 11.26 | 63.57 |
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
Coterra Energy Inc is an independent oil and gas company engaged in the development, exploration, and production of oil, natural gas, and natural gas liquids (NGLs). Its operations are mainly concentrated in areas with hydrocarbon resources, which are conducive to multi-well, repeatable development programs, and include the Permian Basin located in Texas and New Mexico, the Marcellus Shale in northeast Pennsylvania, and the Anadarko Basin located in the mid-continent region in Oklahoma. The company operates in one segment, oil and natural gas development, exploration, and production, in the continental U.S.